PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.14−0.06 (-5.42%)
Close on Nov 20, 2026Market cap $9.08MP/E –Yield –
PAVmed shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
PAVmed's shares outstanding was 6M at Jun 30, 2026. For fiscal 2025 it was 1M, down 69.2% from the year before. Over ten years it grew 38.9% a year on average. The highest annual figure on record is 2M in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | -69.2% |
| FY2024 | Dec 31, 2024 | 2M | +801.6% |
| FY2023 | Dec 31, 2023 | 0M | +21.8% |
| FY2022 | Dec 31, 2022 | 0M | +14.9% |
| FY2021 | Dec 31, 2021 | 0M | +63.4% |
| FY2020 | Dec 31, 2020 | 0M | +57.1% |
| FY2019 | Dec 31, 2019 | 0M | +35.6% |
| FY2018 | Dec 31, 2018 | 0M | +65.1% |
| FY2017 | Dec 31, 2017 | 0M | +4.0% |
| FY2016 | Dec 31, 2016 | 0M | +15.0% |
| FY2015 | Dec 31, 2015 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 6M | +940.0% |
| Q1 FY2026 | Mar 31, 2026 | 2M | -9.5% |
| Q4 FY2025 | Dec 31, 2025 | 1M | +148.0% |
| Q3 FY2025 | Sep 30, 2025 | 1M | -51.5% |
| Q2 FY2025 | Jun 30, 2025 | 1M | +97.6% |
| Q1 FY2025 | Mar 31, 2025 | 2M | +502.7% |
| Q4 FY2024 | Dec 31, 2024 | 0M | +35.0% |
| Q3 FY2024 | Sep 30, 2024 | 1M | +496.0% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +31.6% |
| Q1 FY2024 | Mar 31, 2024 | 0M | +34.3% |
| Q4 FY2023 | Dec 31, 2023 | 0M | +29.2% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +24.7% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +20.0% |
| Q1 FY2023 | Mar 31, 2023 | 0M | +12.5% |
| Q4 FY2022 | Dec 31, 2022 | 0M | +32.2% |
| Q3 FY2022 | Sep 30, 2022 | 0M | +7.7% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +5.7% |
| Q1 FY2022 | Mar 31, 2022 | 0M | +16.7% |
| Q4 FY2021 | Dec 31, 2021 | 0M | +32.8% |
| Q3 FY2021 | Sep 30, 2021 | 0M | +72.2% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +83.6% |
| Q1 FY2021 | Mar 31, 2021 | 0M | +70.0% |
| Q4 FY2020 | Dec 31, 2020 | 0M | +60.0% |
| Q3 FY2020 | Sep 30, 2020 | 0M | +55.9% |
| Q2 FY2020 | Jun 30, 2020 | 0M | +62.2% |
| Q1 FY2020 | Mar 31, 2020 | 0M | +60.2% |
| Q4 FY2019 | Dec 31, 2019 | 0M | +24.5% |
| Q3 FY2019 | Sep 30, 2019 | 0M | +16.9% |
| Q2 FY2019 | Jun 30, 2019 | 0M | +43.1% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +64.1% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +90.3% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +99.1% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +44.7% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +24.1% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +5.0% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +0.2% |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?